Search research articles
Contact Us
Filters
Showing results (21-30 of 92) with videos related to
Page
of 10
Sort By:
Pneumonia (Nathan Qld.)
|
January 25, 2021
HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors - a case report
Johannes Sumer, Frederike Waldeck, Nadja Fischer, et al.
Journal of Geriatric Oncology
|
October 8, 2018
Multidisciplinary treatment of lung cancer in older patients: A review
Marco Radovic, Ravindran Kanesvaran, Achim Rittmeyer, et al.
Current Oncology (Toronto, Ont.)
|
November 24, 2023
A Literature Review of Racial Disparities in Prostate Cancer Research
Matthieu Vermeille, Kira-Lee Koster, David Benzaquen, et al.
Oncoimmunology
|
October 4, 2023
Non-pharmaceutical interventions to optimize cancer immunotherapy
Maximilian Boesch, Florent Baty, Frank Rassouli, et al.
Oncology Research and Treatment
|
November 18, 2016
SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer
Paul M Putora, Kinga Szentesi, Markus Glatzer, et al.
Clinical & Experimental Metastasis
|
January 29, 2015
Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC)
Paul Martin Putora, Silvia Ess, Cedric Panje, et al.
British Journal of Cancer
|
April 7, 2021
Tumour neoantigen mimicry by microbial species in cancer immunotherapy
Maximilian Boesch, Florent Baty, Sacha I Rothschild, et al.
Geospatial Health
|
June 5, 2013
Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland
Verena Jürgens, Silvia Ess, Harish C Phuleria, et al.
Plos One
|
June 28, 2021
Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study
Julia Fuchs, Martin Früh, Alexandros Papachristofilou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem, Sabine Schmid, Mirjam Krapf, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 92) with videos related to
Sort By:
Page
of 10
Pneumonia (Nathan Qld.)
|
January 25, 2021
HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors - a case report
Johannes Sumer, Frederike Waldeck, Nadja Fischer, et al.
Journal of Geriatric Oncology
|
October 8, 2018
Multidisciplinary treatment of lung cancer in older patients: A review
Marco Radovic, Ravindran Kanesvaran, Achim Rittmeyer, et al.
Current Oncology (Toronto, Ont.)
|
November 24, 2023
A Literature Review of Racial Disparities in Prostate Cancer Research
Matthieu Vermeille, Kira-Lee Koster, David Benzaquen, et al.
Oncoimmunology
|
October 4, 2023
Non-pharmaceutical interventions to optimize cancer immunotherapy
Maximilian Boesch, Florent Baty, Frank Rassouli, et al.
Oncology Research and Treatment
|
November 18, 2016
SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer
Paul M Putora, Kinga Szentesi, Markus Glatzer, et al.
Clinical & Experimental Metastasis
|
January 29, 2015
Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC)
Paul Martin Putora, Silvia Ess, Cedric Panje, et al.
British Journal of Cancer
|
April 7, 2021
Tumour neoantigen mimicry by microbial species in cancer immunotherapy
Maximilian Boesch, Florent Baty, Sacha I Rothschild, et al.
Geospatial Health
|
June 5, 2013
Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland
Verena Jürgens, Silvia Ess, Harish C Phuleria, et al.
Plos One
|
June 28, 2021
Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study
Julia Fuchs, Martin Früh, Alexandros Papachristofilou, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 26, 2017
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem, Sabine Schmid, Mirjam Krapf, et al.
Page
of 10